Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Results presented from head-to-head phase II study of pateclizumab versus adalimumab

June 18, 2013

New CCR1 and CCR6 receptor inhibitors for the treatment of rheumatoid arthritis described

June 18, 2013

Bristol-Myers Squibb and Simcere to develop and commercialize Orencia in China

June 17, 2013

First phase II results of novel cPLA2 inhibitor for rheumatoid arthritis

June 14, 2013

FDA approves Xgeva to treat giant cell tumor of bone

June 14, 2013

Daiichi Sankyo launches Pralia in Japan

June 12, 2013

TissueGene-C therapy evaluated in patients with knee osteoarthritis

June 11, 2013

EMA approves RoActemra for polyarticular juvenile idiopathic arthritis

June 10, 2013

IL-23 receptor modulator peptide shows potential in animal models of arthritis

June 6, 2013

UMC Utrecht Holding divulges new fusion proteins

June 6, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...